ABOUT USOUR SCIENCEOUR TEAM
PARTNERING
INVESTMENTLATEST NEWSCAREERS
GET IN TOUCH
About Us
Our Science
Our Team
partnering
Business Development
Scientific Collaboration
Investment
Latest News
Careers
GET IN TOUCH
ABOUT USOUR SCIENCEOUR TEAM
PARTNERING
INVESTMENTLATEST NEWSCAREERS
GET IN TOUCH

Latest News

Keep up to date with the latest news from Pilatus Biosciences.

News

December 15, 2025

Pilatus Biosciences Announces FDA Clearance of IND Application for PLT012, a First-in-Class Anti-CD36 Metabolic Checkpoint Antibody in Solid Tumors

December 8, 2025

Pilatus Biosciences is Selected for LabCentral New Cambridge-Based Educational Program

October 30, 2025

Pilatus Biosciences to Present New Preclinical Data Highlighting PLT012’s Ability to Induce Durable Anti-Tumor Immunity Through Immunometabolic Reprogramming of the Tumor Microenvironment at SITC 2025 Annual Meeting

October 14, 2025

Pilatus Biosciences Announces Issuance of Foundational Global Patent Covering Novel CD36-Targeted Immunotherapy

Upcoming Events

May 4, 2026

-

May 5, 2026

Basel

Swiss Biotech Day

More Info

May 11, 2026

-

May 12, 2026

Hong Kong

Asia Summit on Global Health

More Info

May 27, 2026

-

May 30, 2026

Barcelona

EASL Congress 2026

More Info

May 29, 2026

-

June 2, 2026

Chicago

ASCO Annual Meeting

More Info

Unlocking Immune Potential with
Innovative Metabolic Reprogramming

Pilatus Biosciences

Pilatus Biosciences SA
Route de la Corniche 6
1066 Epalinges
Vaud - SWITZERLAND
Pilatus Biosciences Corp
17F-1, No. 508, Section 7,
Zhongxiao East Road,
Nangang District, 
Taipei City 115, Taiwan
info@pilatusbio.com

Links

AboutOur ScienceOur TeamBusiness
DevelopmentScientific
CollaborationLatest NewsCareers

© 2025 Pilatus Biosciences. All Rights Reserved.

Privacy Policy